Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Walden

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Ecancermedicalscience|January 26, 2012
Cancer stem cells in melanomaC Regenbrecht, Y Welte, R Hugel, et al.
European Journal of Sport Science|March 22, 2023
Blood flow restricted walking alters gait kinematicsThomas P Walden, Timothy Fairchild, Olivier Girard, et al.
Ecancermedicalscience|January 26, 2012
Molecular characterization of signalling pathways in cancer stem cellsC Regenbrecht, Y Welte, A Jodicke, et al.
Plos One|September 4, 2024
Association of social vulnerability factors with power outage burden in Washington state: 2018-2021Claire A Richards, Solmaz Amiri, Von P Walden, et al.
Circulation|March 17, 2004
Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillationDerick M Todd, Simon P Fynn, Andrew P Walden, et al.
Immunology|July 1, 1994
Analysis of a naturally occurring HLA class I-restricted viral epitopeK Falk, O Rötzschke, S Stevanović, et al.
European Journal of Applied Physiology|July 25, 2020
Sessional work-rate does not affect the magnitude to which simulated hypoxia can augment acute physiological responses during resistance exerciseThomas P Walden, Olivier Girard, Andrew M Jonson, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1993
The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin AP H Gilligan, T P Walden, W F Kelly, et al.
Applied Optics|January 22, 2010
Improvements in the data quality of the Interferometric Monitor for Greenhouse GasesVon P Walden, Robin L Tanamachi, Penny M Rowe, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Ecancermedicalscience|January 26, 2012
Cancer stem cells in melanomaC Regenbrecht, Y Welte, R Hugel, et al.
European Journal of Sport Science|March 22, 2023
Blood flow restricted walking alters gait kinematicsThomas P Walden, Timothy Fairchild, Olivier Girard, et al.
Ecancermedicalscience|January 26, 2012
Molecular characterization of signalling pathways in cancer stem cellsC Regenbrecht, Y Welte, A Jodicke, et al.
Plos One|September 4, 2024
Association of social vulnerability factors with power outage burden in Washington state: 2018-2021Claire A Richards, Solmaz Amiri, Von P Walden, et al.
Circulation|March 17, 2004
Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillationDerick M Todd, Simon P Fynn, Andrew P Walden, et al.
Immunology|July 1, 1994
Analysis of a naturally occurring HLA class I-restricted viral epitopeK Falk, O Rötzschke, S Stevanović, et al.
European Journal of Applied Physiology|July 25, 2020
Sessional work-rate does not affect the magnitude to which simulated hypoxia can augment acute physiological responses during resistance exerciseThomas P Walden, Olivier Girard, Andrew M Jonson, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1993
The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin AP H Gilligan, T P Walden, W F Kelly, et al.
Applied Optics|January 22, 2010
Improvements in the data quality of the Interferometric Monitor for Greenhouse GasesVon P Walden, Robin L Tanamachi, Penny M Rowe, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
A phase I trial with a hybrid cell vaccine in patients with metastatic melanomaU Trefzer, G Weingart, Y Chen, et al.
Pageof 12